As of 2026-09-12, the EV/EBITDA ratio of BELLUS Health Inc (BLU.TO) is -26.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLU.TO's latest enterprise value is 2,353.00 mil CAD. BLU.TO's TTM EBITDA according to its financial statements is -90.49 mil CAD. Dividing these 2 quantities gives us the above BLU.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.5x - 3.8x | 3.2x |
| Forward P/E multiples | 2.5x - 3.8x | 3.2x |
| Fair Price | (1.58) - (2.83) | (2.20) |
| Upside | -108.1% - -114.5% | -111.3% |
| Date | EV/EBITDA |